P
Philip C. Calder
Researcher at University of Southampton
Publications - 808
Citations - 70822
Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
Timothy M Trebble,Stephen A. Wootton,Mike Stroud,Mark Mullee,Philip C. Calder,David R. Fine,Caje Moniz,Nigel K Arden +7 more
TL;DR: The power of simple markers of systemic inflammation to identify higher rates of bone loss, in Crohn's disease, is uncertain and the role of circulating (peripheral blood) mononuclear cells was investigated in a case–control study.
Journal ArticleDOI
Is Increasing Microbiota Diversity a Novel Anti-Inflammatory Action of Marine n-3 Fatty Acids?
Journal ArticleDOI
Characterising the nutritional status of children with primary ciliary dyskinesia.
Luise V. Marino,Amanda Harris,C. Johnstone,Amanda Friend,Colin Newell,Elizabeth A. Miles,Jane S. Lucas,Jane S. Lucas,Philip C. Calder,Philip C. Calder,Woolf T. Walker,Woolf T. Walker +11 more
TL;DR: The nutritional phenotype of a cohort of children with primary ciliary dyskinesia was characterised and a weak association between lung function and nutritional status, and measures of BIS phase-angle were found.
Journal ArticleDOI
Metabolic syndrome: epidemiology, pathophysiology, and nutrition intervention.
TL;DR: Suggestion that hypoadiponectinemia may exert a fundamental role in the passage from visceral obesity to MetS is reinforced, as four articles evaluate the role of inflammation and adipocytokines on the syndrome.
Journal ArticleDOI
Fat as a physiological regulator: the news gets better.
TL;DR: Emerging evidence is providing more support for the role of specific benefits of n-3 polyunsaturated fatty acids (PUFAs) in decreasing risk of cardiovascular disease, and modulating inflammation and the immune response, and for innovative roles of these fatty acids in clinical nutrition.